Deficiency of Aph1B/C-γ-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment

T. Dejaegere, L. Serneels, M. K. Schäfer, J. Van Biervliet, K. Horré, C. Depboylu, D. Alvarez-Fischer, A. Herreman, M. Willem, C. Haass, G. U. Höglinger, R. D'Hooge, B. De Strooper*

*Corresponding author for this work
58 Citations (Scopus)

Abstract

Regulated intramembrane proteolysis by γ-secretase cleaves proteins in their transmembrane domain and is involved in important signaling pathways. At least four different γ-secretase complexes have been identified, but little is known about their biological role and specificity. Previous work has demonstrated the involvement of the Aph1A-γ-secretase complex in Notch signaling, but no specific function could be assigned to Aph1B/C-γ- secretase. We demonstrate here that the Aph1B/C-γ-secretase complex is expressed in brain areas relevant to schizophrenia pathogenesis and that Aph1B/C deficiency causes pharmacological and behavioral abnormalities that can be reversed by antipsychotic drugs. At the molecular level we find accumulation of Nrg1 fragments in the brain of Aph1BC-/- mice. Our observations gain clinical relevance by the demonstration that a Val-to-Leu mutation in the Nrg1 transmembrane domain, associated with increased risk for schizophrenia, affects γ-secretase cleavage of Nrg1. This finding suggests that dysregulation of intramembrane proteolysis of Nrg1 could increase risk for schizophrenia and related disorders.

Original languageEnglish
JournalProceedings of the National Academy of Sciences of the United States of America
Volume105
Issue number28
Pages (from-to)9775-9780
Number of pages6
ISSN0027-8424
DOIs
Publication statusPublished - 15.07.2008

Fingerprint

Dive into the research topics of 'Deficiency of Aph1B/C-γ-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment'. Together they form a unique fingerprint.

Cite this